Trinity Biotech (TRIB) Asset Utilization Ratio (2009 - 2024)

Trinity Biotech has disclosed Asset Utilization Ratio across 16 years of filings, most recently posting 0.61 for Q4 2024.

• Asset Utilization Ratio for Q4 2024 came in at 0.61, down 33.61% year-over-year; the trailing twelve-month figure through Dec 2024 was 0.61 (down 33.61% YoY), and the FY2025 annual result was 0.42, down 44.47% from the prior year.
• Asset Utilization Ratio came in at 0.61 for Q4 2024 at Trinity Biotech, down from 0.62 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.92 in Q4 2023 to a low of 0.61 in Q4 2024.
• The 5-year median for Asset Utilization Ratio is 0.71 (2023), against an average of 0.73.
• Across the five-year window, Asset Utilization Ratio jumped 40.38% in 2023 and slumped 33.61% in 2024, its largest moves.
• Trinity Biotech's Asset Utilization Ratio stood at 0.77 in 2020, then grew by 0.51% to 0.77 in 2021, then fell by 14.46% to 0.66 in 2022, then surged by 40.38% to 0.92 in 2023, then plunged by 33.61% to 0.61 in 2024.
• The last three Asset Utilization Ratio figures came in at 0.61 (Q4 2024), 0.62 (Q3 2024), and 0.64 (Q2 2024), per Business Quant data.